News & Updates

Use of oral bisphosphonate or denosumab does not appear to increase the risk of cardiovascular events (CVEs), namely acute myocardial infarction, unstable angina, cerebrovascular accident, and transient ischemic attack, in persons with incident fracture, a study has shown.

Children born to mothers who had contracted hepatitis B virus (HBV) infection before pregnancy appear to be at increased risk of congenital heart diseases (CHDs), as reported in a study.

The incidence of major vascular complications among patients who underwent noncardiac surgery is similar between hypotension- and hypertension-avoidance strategies, reports a study.

A recent study conducted in Nigeria from December 2019 to February 2020 has revealed many individuals with little to no awareness of hypertension self-management practices.

Use of nonvitamin K antagonist oral anticoagulants (NOACs) helps prevent thromboembolic events in Asian patients with atrial fibrillation (AF), with fewer bleeding events relative to warfarin therapy, according to the results of a study presented at the recent EHRA 2023.

Women with prenatal depression appears to have an elevated cumulative risk of developing cardiovascular disease (CVD) within 24 months postpartum, with the risk persisting despite the absence of co‐occurring hypertensive disorders of pregnancy, as reported in a study.